Multiple MolDX Policies- MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis and MolDX: Genetic Testing for Heritable Thoracic Aortic Disease - Published for Review and Comments

Date Posted: August 29, 2024

This proposed Local Coverage Determination (LCD) has been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number: DL39948

Medicare Coverage Database (MCD) Number: DL39944

LCD Title: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis DL39948

LCD Title: MolDX: Genetic Testing for Heritable Thoracic Aortic Disease DL39944

Comment period: August 29, 2024-October 12, 2024

Visit the CMS MCD to access Proposed LCDs not released to final LCDs.

Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed MolDX LCDs webpage for email and mail specifics.

Last Updated Aug 29 , 2024